Skip to main content.


Picture of Pauline Bartolone

Despite recent cost-cutting measures, California’s spending on pharmaceuticals has gone up, and so has the number of pricey drugs it is covering. It’s not clear state agencies have the means to balance drug cost pressures with the best interests of patients, taxpayers and public health.

Picture of Pauline Bartolone

An unlikely coalition of health insurers, labor and consumer advocates are pushing for controls on high-cost drugs in the nation's most populous state. “California is truly ground zero for this fight,” one advocate said. “It is clear Congress as a whole is not going to take meaningful action."

Picture of Pauline Bartolone

California says the expense of new hep C drugs has nothing to do with who is prescribed them. But the question lingers: With some 200,000 people living with hep C in Medi-Cal, how much of a factor is cost in determining which patients receive treatment?

Picture of Rebecca Plevin

New hepatitis C treatments are both staggeringly effective and expensive. This has sparked a nationwide discussion about the high cost of specialty drugs and how such costs are keeping patients from needed treatments. Prescribing data may offer new insights.

Picture of Kristin Gourlay

What’s the price of a human life? In this part of our series “At the Crossroads: The Rise of Hepatitis C and The Fight To Stop It,” we'll tell you what value health economists put on human life.

Picture of Kristin Gourlay

Like a growing number of Medicaid programs around the country, Rhode Island’s Medicaid program has quietly posted its first guidelines for coverage of an expensive new drug for hepatitis C. The new drug, called Sovaldi, is a big deal, whether you have hepatitis C or not.


“Racism in medicine is a national emergency.” That’s how journalist Nicholas St. Fleur characterized the crisis facing American health care this spring, as his team at STAT embarked on “Color Code,” an eight-episode series exploring medical mistrust in communities of color across the country. In this webinar, we’ll take inspiration from their work to discuss strategies and examples for telling stories about inequities, disparities and racism in health care systems. Sign-up here!

The USC Center for Health Journalism at the Annenberg School for Communication and Journalism is seeking two Engagement Editors to serve as thought leaders in one of the most innovative and rewarding arenas in journalism today – “engaged reporting” that puts the community at the center of the reporting process. Learn more about the positions and apply to join our team.


Follow Us



CHJ Icon